<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the effects of 2-(<z:chebi fb="0" ids="30361">allyl</z:chebi>-1-piperazinyl)-4-n-amyloxyquinazoline fumarate (KB-5666) on <z:hpo ids='HP_0002181'>brain edema</z:hpo> and histological neuronal damage in rats with focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and on <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation in brain homogenates and brain mitochondria in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>KB-5666 (3-100 microM) inhibited <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation in brain homogenates and mitochondria, and also inhibited <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> swelling </plain></SENT>
<SENT sid="2" pm="."><plain>In a rat with middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, administration of KB-5666 (3 and 10 mg/kg) immediately after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> prevented the formation of <z:hpo ids='HP_0002181'>brain edema</z:hpo> in the cortex and ameliorated the histological neuronal damage in the same area, but failed to do so in the striatum </plain></SENT>
<SENT sid="3" pm="."><plain>These results indicate that KB-5666 is a potential inhibitor of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation that could possibly prevent ischemic complications such as formation of <z:hpo ids='HP_0002181'>brain edema</z:hpo> and neuronal damage </plain></SENT>
<SENT sid="4" pm="."><plain>Further, these results suggest that <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation may play an important role in the pathogenesis of ischemic damage after focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>